E
Neumora Therapeutics, Inc. NMRA
$1.28 -$0.12-8.57%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -58.82M -72.55M -58.70M -53.72M -108.73M
Total Depreciation and Amortization 157.00K 156.00K 160.00K 158.00K 166.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 9.68M 9.47M 11.42M 7.02M 70.23M
Change in Net Operating Assets -1.36M 29.43M -9.03M 3.59M -13.11M
Cash from Operations -50.34M -33.48M -56.16M -42.96M -51.44M
Capital Expenditure 775.00K 0.00 0.00 -775.00K -44.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -99.57M 156.99M 21.26M -149.23M 13.72M
Cash from Investing -98.80M 156.99M 21.26M -150.00M 13.68M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 15.35M 1.76M 2.65M 1.85M 339.00K
Repurchase of Common Stock -- -- -- -- 0.00
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 225.00K -225.00K -- -- -820.00K
Cash from Financing 15.57M 1.53M 2.65M 1.85M -481.00K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -133.57M 125.04M -32.25M -191.11M -38.25M
Weiss Ratings